Resource Summary

Clinical Question:
Are the serious adverse events associated with long-acting beta-agonists (LABA) in asthma important enough to limit their use?

Bottom-line:
In asthmatic patients^ LABA should not be used without inhaled steroids because^ alone^ LABA inhalers cause an increase in serious adverse events. It is difficult to determine if asthma patients who use LABA in conjunction with an inhaled steroid are at increased risk^ but if so^ it is likely in the range of one in 3^334 patients. LABA does not increase adverse events in COPD patients.


*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2013-10-28
Last Updated on PCR: 2017-03-31 16:14:38